Skip to main content
SpringerLink
Log in

The Placebo and Nocebo Effects in Cancer Treatment

  • Chapter
  • First Online:
Psychological Aspects of Cancer

Abstract

In the field of cancer research both placebo and nocebo effects are observed. Thereby, not only the application of an inert substance or procedure, the placebo, but the whole therapeutic context in which a treatment is given has the potential to cause placebo and nocebo effects. Two central mechanisms are hypothesized to play important roles in their development and maintenance: expectations and conditioning. Psycho-(neuro-)biological underpinnings that correlate with placebo and nocebo effects are called placebo and nocebo responses, and support the existence of the true placebo and nocebo effects. Individual patients treated with placebos in randomized controlled trials report improvements in various cancer-related symptoms like fatigue, nausea, pain, or vasomotor symptoms. Improvement on an average group level in placebo arms could be shown for cancer-related pain, but not for weight gain or performance status. No significant placebo-induced improvements in tumor response have been shown so far. Besides desirable changes, patients in the placebo arms also report adverse events. As these unspecific side effects tend to mimic the side effect profiles of the active treatment, a priori expectations about potential side effects are thought to be relevant. Expectation and conditioning as well as their interactions are important pathways for placebo and nocebo effects. For example, the development of nausea related to chemotherapy can be seen as a result of expectations, conditioning, and their interacting processes. However, until today systematic evaluations of placebo and nocebo effects in cancer trials remain rare and especially methodologically sound integrations of effects are needed. With regard to ethical issues, demonstration of placebo and nocebo effects in cancer treatment outcome highlights considerations for enhancing placebo while decreasing nocebo effects to improve the patients’ care.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Atlas LY, Wager TD, William PB. The placebo response. Encyclopedia of consciousness. Oxford: Academic Press; 2009:201–16.

    Google Scholar 

  2. Zhang Z, Wang Y, Wang Y, Xu F. Antiemetic placebo: reduce adverse drug interactions between chemotherapeutic agents and antiemetic drugs in cancer patients. Med Hypotheses. 2008;70(3):551–5.

    Article  PubMed  CAS  Google Scholar 

  3. Edward SJL, Stevens AJ, Braunholtz DA, Lilford RJ, Swift T. The ethics of placebo-controlled trials: a comparison of inert and active placebo controls. World J Surg. 2005;29(5):610–4.

    Article  PubMed  Google Scholar 

  4. Aronson J. Please, please me. BMJ. 1999; 318(7185):716.

    Google Scholar 

  5. Price DD, Finniss DG, Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol. 2008;59(1):565–90.

    Article  PubMed  Google Scholar 

  6. Miller FG, Kaptchuk TJ. The power of context: reconceptualizing the placebo effect. J R Soc Med. 2008;101(5):222–5.

    Article  PubMed  Google Scholar 

  7. Temple RJ. Implications of effects in placebo groups. J Natl Cancer Inst. 2003;95(1):2.

    Article  PubMed  Google Scholar 

  8. Kennedy WP. The nocebo reaction. Med World. 1961;95:203–5.

    Google Scholar 

  9. Enck P, Benedetti F, Schedlowski M. New insights into the placebo and nocebo responses. Neuron. 2008;59(2):195–206.

    Article  PubMed  CAS  Google Scholar 

  10. Barsky AJ, Saintfort R, Rogers MP, Borus JF. Nonspecific medication side effects and the nocebo phenomenon. JAMA. 2002;287:622–7.

    Google Scholar 

  11. Hahn RA. The nocebo phenomenon: concept, evidence, and implications for public health. Prev Med. 1997;26:607–11.

    Article  PubMed  CAS  Google Scholar 

  12. Colloca L, Petrovic P, Wager TD, Ingvar M, Benedetti F. How the number of learning trials affects placebo and nocebo responses. Pain. 2010;151(2):430–9.

    Article  PubMed  Google Scholar 

  13. Shepherd M. The placebo: from specificity to the non-specific and back. Psychol Med. 1993;23(03):569–78.

    Article  PubMed  CAS  Google Scholar 

  14. Rief W, Nestoriuc Y, von Lilienfeld-Toal A, et al. Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis. Drug Saf. 2009;32:1041–56.

    Article  PubMed  CAS  Google Scholar 

  15. Rief W, Avorn J, Barsky AJ. Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects. Arch Intern Med. 2006;166(2):155–60.

    Article  PubMed  Google Scholar 

  16. Amanzio M, Corazzini LL, Vase L, Benedetti F. A systematic review of adverse events in placebo groups of anti-migraine clinical trials. Pain. 2009;146(3):261–9.

    Article  PubMed  CAS  Google Scholar 

  17. National Comprehensive Cancer Network. Cancer related fatigue. Clinical practice guidelines in oncology. Fort Washington, PA: National Comprehensive Cancer Network; 2011.

    Google Scholar 

  18. Cella D, Davis K, Breitbart W, Curt G. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol. 2001;19(14):3385.

    PubMed  CAS  Google Scholar 

  19. Minton O, Richardson A, Sharpe M, Hotopf M, Stone PC. Psychostimulants for the management of cancer-related fatigue: a systematic review and meta-analysis. J Pain Symptom Manage. 2011;41(4):761–7.

    Article  PubMed  CAS  Google Scholar 

  20. Wagner LI, Cella D. Fatigue and cancer: causes, prevalence and treatment approaches. Br J Cancer. 2004;91(5):822–8.

    PubMed  CAS  Google Scholar 

  21. de la Cruz M, Hui D, Parsons HA, Bruera E. Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer. Cancer. 2010;116(3):766–74.

    Article  PubMed  Google Scholar 

  22. Schwartzberg L. Chemotherapy-induced nausea and vomiting: state of the art in 2006. J Support Oncol. 2006;4(2 Suppl 1):3–8.

    PubMed  CAS  Google Scholar 

  23. Robb KA, Newham DJ, Williams JE. Transcutaneous electrical nerve stimulation vs transcutaneous spinal electroanalgesia for chronic pain associated with breast cancer treatments. J Pain Symptom Manage. 2007;33(4):410–9.

    Article  PubMed  Google Scholar 

  24. Eija k, Tiina T, Pertti J N. Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer. Pain. 1996;64(2):293–302.

    Google Scholar 

  25. Chvetzoff Gl, Tannock IF. Placebo effects in oncology. J Natl Cancer Inst. 2003;95(1):19–29.

    Google Scholar 

  26. Benedetti F, Amanzio M, Vighetti S, Asteggiano G. The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J Neurosci. 2006;26(46): 12014–22.

    Google Scholar 

  27. Finck G, Barton DL, Loprinzi CL, Quella SK, Sloan JA. Definitions of hot flashes in breast cancer survivors. J Pain Symptom Manage. 1998;16(5):327–33.

    Article  PubMed  CAS  Google Scholar 

  28. Kaplan M, Mahon S, Cope D, Keating E, Hill S, Jacobson M. Putting evidence into practice: evidence-based interventions for hot flashes resulting from cancer therapies. Clin J Oncol Nurs. 2011;15(2):149–57.

    Article  PubMed  Google Scholar 

  29. Boekhout AH, Beijnen JH, Schellens JHM. Symptoms and treatment in cancer therapy-induced early menopause. Oncologist. 2006;11(6):641.

    Article  PubMed  CAS  Google Scholar 

  30. Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H. Methodologic lessons learned from hot flash studies. J Clin Oncol. 2001;19(23):4280–90.

    Google Scholar 

  31. Pandya KJ, Raubertas RF, Flynn PJ, et al. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study. Ann Intern Med. 2000;132(10):788.

    PubMed  CAS  Google Scholar 

  32. Inui A. Cancer anorexia cachexia syndrome: current issues in research and management. CA Cancer J Clin. 2002;52(2):72–91.

    Article  PubMed  Google Scholar 

  33. Conill C, Verger E, Salamero M. Performance status assessment in cancer patients. Cancer. 1990;65(8): 1864–6.

    Article  PubMed  CAS  Google Scholar 

  34. Pavlov IP. Conditional reflexes. an investigation of the psychological activity of the cerebral cortex. London: Oxford University Press; 1927.

    Google Scholar 

  35. Colloca L, Miller FG. Role of expectations in health. Curr Opin Psychiatry. 2011;24(2):149.

    Article  PubMed  Google Scholar 

  36. Leventhal H, Nerenz D, Steele DJ. Illness representations and coping with health threats. In: Baum A, Taylor SE, Singer JE, editors. Handbook of Psychology and Health. Volume IV. Social Psychology aspects of health. Hillsdale, NJ: Erlbaum; 1984. p. 219–52.

    Google Scholar 

  37. Rozema H, Völlink T, Lechner L. The role of illness representations in coping and health of patients treated for breast cancer. Psychooncology. 2009;18(8):849–57.

    Article  PubMed  Google Scholar 

  38. Roscoe JA, Jean-Pierre P, Shelke AR, Kaufman ME, Bole C, Morrow GR. The role of patients‘ response expectancies in side effect development and control. Curr Problem Cancer. 2006;30(2):40–98.

    Google Scholar 

  39. Kirsch I. Response expectancy theory and application: a decennial review. Appl Prev Psychol. 1997;6:69–79.

    Article  Google Scholar 

  40. Sohl SJ, Schnur JB, Montgomery GH. A meta-analysis of the relationship between response expectancies and cancer treatment-related side effects. J Pain Symptom Manage. 2009;38(5):775–84.

    Google Scholar 

  41. Hitckok JT, Roscoe JA, Morrow GR. The role of patients expectations in the developement of anticipatory nausea related to chemotherapy for cancer. J Pain Symptom Manage. 2001;22(4):843–50.

    Google Scholar 

  42. Colagiuri B, Roscoe JA, Morrow GR, Atkins JN, Giguere JK, Colman LK. How do patient expectancies, quality of life, and postchemotherapy nausea interrelate? Cancer. 2008;113(3):654–61.

    Article  PubMed  Google Scholar 

  43. Higgins S, Montgomery G, Bovbjerg D. Distress before chemotherapy predicts delayed but not acute nausea. Support Care Cancer. 2007;15(2):171–7.

    Article  PubMed  Google Scholar 

  44. Roscoe JA, Hickok JT, Morrow GR. Patient expectations as predictor of chemotherapy-induced nausea. Ann Behav Med. 2000;22(2):121–6.

    Google Scholar 

  45. Hofman M, Morrow GR, Roscoe JA, et al. Cancer patients‘ expectations of experiencing treatment-related side effects. Cancer. 2004;101(4):851–7.

    Google Scholar 

  46. Rief W, Broadbent E. Explaining medically unexplained symptoms-models and mechanisms. Clin Psychol Rev. 2007;27(7):821–41.

    Article  PubMed  Google Scholar 

  47. Geers AL, Weiland PE, Kosbab K, Landry SJ, Helfer SG. Goal activation, expectations, and the placebo effect. J Pers Soc Psychol. 2005;89(2):143.

    Article  PubMed  Google Scholar 

  48. Finniss DG, Kaptchuk TJ, Miller F, Benedetti F. Biological, clinical, and ethical advances of placebo effects. Lancet. 2010;375(9715):686–95.

    Google Scholar 

  49. Colloca L, Sigaudo M, Benedetti F. The role of learning in nocebo and placebo effects. Pain. 2008; 136(1–2):211–8.

    Article  PubMed  CAS  Google Scholar 

  50. Benedetti F, Pollo A, Lopiano L, Lanotte M, Vighetti S, Rainero I. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci. 2003;23(10):4315–23.

    Google Scholar 

  51. Goebel MU, Trebst AE, Steiner JAN, et al. Behavioral conditioning of immunosuppression is possible in humans. FASEB J. 2002;16(14):1869.

    Article  PubMed  CAS  Google Scholar 

  52. Levine J, Gordon N, Fields H. The mechanisms of placebo analgesia. Lancet. 1978;312(8091):654–7.

    Article  Google Scholar 

  53. Wager TD, Scott DJ, Zubieta J-K. Placebo effects on human μ-opioid activity during pain. Proc Natl Acad Sci. 2007;104(26):11056–61.

    Google Scholar 

  54. Kong J, Gollub RL, Polich G, et al. A functional magnetic resonance imaging study on the neural mechanisms of hyperalgesic nocebo effect. J Neurosci. 2008;28(49):13354–62.

    Google Scholar 

  55. Flaten MA, Simonsen T, Olsen H. Drug-related information generates placebo and nocebo responses that modify the drug response. Psychosom Med. 1999;61(2):250–5.

    Google Scholar 

  56. Moerman DE, Jonas WB. Deconstructing the placebo effect and finding the meaning response. Ann Intern Med. 2002;136(6):471–6.

    Google Scholar 

  57. Baile WF, Buckman R, Lenzi R, Glober G, Beale EA, Kudelka AP. SPIKES – a six-step protocol for delivering bad news: application to the patient with cancer. Oncologist. 2000;5(4):302–11.

    Google Scholar 

  58. Sardell AN, Trierweiler SJ. Disclosing the cancer diagnosis. Procedures that influence patient hopefulness. Cancer. 1993;72(11):3355–65.

    Article  PubMed  CAS  Google Scholar 

  59. Roberts CS, Cox CE, Reintgen DS, Baile WF, Gibertini M. Influence of physician communication on newly diagnosed breast patients’ psychologic adjustment and decision making. Cancer. 1994; 74(S1):336–41.

    Article  PubMed  CAS  Google Scholar 

  60. Last BF, Van Veldhuizen AMH. Information about diagnosis and prognosis related to anxiety and depression in children with cancer aged 8–16 years. Eur J Cancer. 1996;32(2):290–4.

    Article  Google Scholar 

  61. Stumpenhorst M, Seifart C, Seifart U, Rief W. Breaking bad news badly? -Wie Krebsdiagnosen Patienten vermittelt werden. Poster presented at the 7th Workshopcongress of the German Psychological Society (Clinical Psychology and Psychotherapy Section), Berlin, Germany; 2011.

    Google Scholar 

  62. Pollo A, Amanzio M, Arslanian A, Casadio C, Maggi G, Benedetti F. Response expectancies in placebo analgesia and their clinical relevance. Pain. 2001; 93(1):77–84.

    Article  PubMed  CAS  Google Scholar 

  63. Benedetti F, Lanotte M, Lopiano L, Colloca L. When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience. 2007;147(2):260–71.

    Article  PubMed  CAS  Google Scholar 

  64. Daugherty CK, Ratain MJ, Emanuel EJ, Farrell AT, Schilsky RL. Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials. J Clin Oncol. 2008;26(8):1371–8.

    Google Scholar 

  65. Freedman B. Equipoise and the ethics of clinical research. Bioethics Anthol. 1999;317(3):45.

    Google Scholar 

  66. Rief W. Lessons to be learned from placebo groups in clinical trials. Pain. 2011;152(8):1693–94.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Psychology and Psychotherapy, Deparment of Psychology, Philipps University Marburg, Gutenbergstrasse 18, 35037, Marburg, Germany

    Franziska Schuricht & Yvonne Nestoriuc Ph.D.

Authors
  1. Franziska Schuricht
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yvonne Nestoriuc Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yvonne Nestoriuc Ph.D. .

Editor information

Editors and Affiliations

  1. Kimmel Cancer Center, Thomas Jefferson University, S. 10th Street 233, Philadelphia, 19107, Pennsylvania, USA

    Brian I. Carr

  2. STARZL TRANSPLAN INST, University of Pittsburgh, 5TH AVE 7 MONTEFIORE 3459, PITTSBURGH, 15213, Pennsylvania, USA

    JENNIFER STEEL

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Schuricht, F., Nestoriuc, Y. (2013). The Placebo and Nocebo Effects in Cancer Treatment. In: Carr, B., STEEL, J. (eds) Psychological Aspects of Cancer. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-4866-2_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-4866-2_18

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4614-4865-5

  • Online ISBN: 978-1-4614-4866-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation